Kunikata Hiroshi, Abe Toshiaki, Nishida Kohji
Department of Ophthalmology and Visual Science, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan.
Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec;42(6):487-92. doi: 10.3928/15428877-20110901-01. Epub 2011 Sep 8.
The authors examined the feasibility of performing 25- and 23-gauge micro-incision vitrectomy surgery (MIVS) for a giant retinal tear.
The medical records of 12 eyes of 11 patients with giant retinal tear who underwent MIVS using perfluorocarbon liquids were reviewed. All patients were observed for at least 6 months postoperatively.
An intraoperative re-attachment was achieved in 12 eyes (100%) and 11 eyes (92%) remained attached without intraocular tamponade. Silicone oil was used in 9 of 12 eyes and removed 2 weeks after the initial vitrectomy except in one eye. The postoperative retinal complications included macular pucker in two eyes, subretinal perfluorocarbon liquid in two eyes, retinal folds in one eye, cystoid macular edema in one eye, and redetachment due to proliferative vitreoretinopathy in one eye.
Although the study had a short follow-up period, primary MIVS appears to be safe and feasible for giant retinal tear surgery.
作者探讨了采用25G和23G微切口玻璃体切除术（MIVS）治疗巨大视网膜裂孔的可行性。
回顾性分析11例（12眼）接受采用全氟碳液体的MIVS治疗的巨大视网膜裂孔患者的病历资料。所有患者术后均随访至少6个月。
12眼（100%）术中实现视网膜复位，11眼（92%）未行眼内填充而保持视网膜附着。12眼中9眼使用硅油，除1眼外，其余均在初次玻璃体切除术后2周取出。术后视网膜并发症包括2眼黄斑前膜、2眼视网膜下全氟碳液体、1眼视网膜皱褶、1眼黄斑囊样水肿以及1眼因增生性玻璃体视网膜病变导致视网膜再脱离。
尽管本研究随访时间较短，但初次MIVS治疗巨大视网膜裂孔手术似乎安全可行。
